---
layout: post
title: "雪榕生物披露定增结果：华夏基金获配1.29亿元 UBS AG、财通基金等在列"
date: 2022-03-08 18:04:13 +0800
categories: cailianshe
tags: 财联社新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.300511" data-code="300511|0|2" data-code2="300511|0|80|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.300511&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 300511_0" data-code="K 300511|0|2" data-code2="K 300511|0|80|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>雪榕生物披露2020年度创业板向特定对象发行股票发行情况，确定此次发行价格为6.06元/股，发行数量约为6567.66万股，募资总额约为3.98亿元；发行对象为11名，锁定期为6个月。 <br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203082301232070>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)